Miguel Carda

Affiliations: 
Universitat Jaume I, Spain 
Google:
"Miguel Carda"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pla-López A, Carda M, Falomir E. (2023) Tetrazole derivatives as potent immunomodulatory agents in tumor microenvironment. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 169: 115668
Pla-López A, Martínez-Colomina P, Cañada-García L, et al. (2023) Aryl azoles based scaffolds for disrupting tumor microenvironment. Bioorganic & Medicinal Chemistry. 95: 117490
Gil-Edo R, Royo S, Carda M, et al. (2023) Unveiling the Potential of BenzylethyleneAryl-Urea Scaffolds for the Design of New Onco Immunomodulating Agents. Pharmaceuticals (Basel, Switzerland). 16
Gil-Edo R, Hernández-Ribelles G, Royo S, et al. (2023) Exploring BenzylethoxyAryl Urea Scaffolds for Multitarget Immunomodulation Therapies. International Journal of Molecular Sciences. 24
Gil-Edo R, Espejo S, Falomir E, et al. (2023) Synthesis and Biological Evaluation of Potential Oncoimmunomodulator Agents. International Journal of Molecular Sciences. 24
Pla-López A, Castillo R, Cejudo-Marín R, et al. (2022) Synthesis and Biological Evaluation of Small Molecules as Potential Anticancer Multitarget Agents. International Journal of Molecular Sciences. 23
Martín-Beltrán C, Gil-Edo R, Hernández-Ribelles G, et al. (2021) Aryl Urea Based Scaffolds for Multitarget Drug Discovery in Anticancer Immunotherapies. Pharmaceuticals (Basel, Switzerland). 14
Agut R, Falomir E, Murga J, et al. (2020) Synthesis of Combretastatin A-4 and 3'-Aminocombretastatin A-4 derivatives with Aminoacid Containing Pendants and Study of Their Interaction with Tubulin and as Downregulators of the VEGF, hTERT and c-Myc Gene Expression. Molecules (Basel, Switzerland). 25
Castrillón W, Herrera-R A, Prieto LJ, et al. (2019) Synthesis and Evaluation of S-allyl Cysteine Ester - Caffeic Acid Amide Hybrids as Potential Anticancer Agents. Iranian Journal of Pharmaceutical Research : Ijpr. 18: 1770-1789
Conesa-Milián L, Falomir E, Murga J, et al. (2019) Novel multitarget inhibitors with antiangiogenic and immunomodulator properties. European Journal of Medicinal Chemistry. 170: 87-98
See more...